comparisonWomen over 40 have more delivery options than most peptide guides acknowledge. The choice depends on your primary goal, comfort with injections, and desired systemic versus local effects. 1…
Source: peptidesexplorer.comOpen reference →comparisonPerimenopause and post-menopause present different challenges. The peptide priorities shift as hormonal status changes. Estrogen status Fluctuating, declining Low, stable Primary skin conce…
Source: peptidesexplorer.comOpen reference →comparisonGHK-Cu Skin, hair, collagen Postmenopausal collagen loss Weight-based mcg/kg BPC-157 Healing, gut, tendons Estrogen-depleted wound healing Fixed dose (mcg/day) Retatrutide Metabolic, weight…
Source: pspeptides.comOpen reference →comparisonCJC-1295/Ipamorelin Stimulates pulsatile GH secretion; improves lipolysis and lean mass retention 200–300mcg each, 3–5×/week subcutaneous Body composition changes visible at 8–12 weeks; met…
Source: realpeptides.coOpen reference →comparisonGLP-1 Agonists (Semaglutide, Tirzepatide) Delays gastric emptying, reduces ghrelin rebound, improves insulin sensitivity 0.25mg-2.4mg weekly (titrated over 16-20 weeks) Appetite suppression…
Source: realpeptides.coOpen reference →comparisonBefore selecting a peptide protocol, compare mechanisms, administration logistics, and clinical endpoints relevant to postmenopausal physiology. BPC-157 VEGF upregulation, collagen synthesi…
Source: realpeptides.coOpen reference →